<VariationArchive RecordType="classified" VariationID="1033282" VariationName="NM_014317.5(PDSS1):c.1164_1165del (p.Ile388fs)" VariationType="Deletion" Accession="VCV001033282" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-04-23" DateCreated="2021-03-22" MostRecentSubmission="2021-03-22">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1020721" VariationID="1033282">
      <GeneList>
        <Gene Symbol="PDSS1" FullName="decaprenyl diphosphate synthase subunit 1" GeneID="23590" HGNC_ID="HGNC:17759" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>10p12.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="26697701" stop="26746798" display_start="26697701" display_stop="26746798" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="26986594" stop="27035726" display_start="26986594" display_stop="27035726" Strand="+" />
          </Location>
          <OMIM>607429</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_014317.5(PDSS1):c.1164_1165del (p.Ile388fs)</Name>
      <CanonicalSPDI>NC_000010.11:26746388:AA:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>10p12.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="26746389" stop="26746390" display_start="26746389" display_stop="26746390" variantLength="2" positionVCF="26746388" referenceAlleleVCF="TAA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="27035318" stop="27035319" display_start="27035318" display_stop="27035319" variantLength="2" positionVCF="27035317" referenceAlleleVCF="TAA" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>I218fs</ProteinChange>
      <ProteinChange>I388fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.10" sequenceAccession="NC_000010" sequenceVersion="10" change="g.27035318_27035319del" Assembly="GRCh37">
            <Expression>NC_000010.10:g.27035318_27035319del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.11" sequenceAccession="NC_000010" sequenceVersion="11" change="g.26746389_26746390del" Assembly="GRCh38">
            <Expression>NC_000010.11:g.26746389_26746390del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008972.2" sequenceAccession="NG_008972" sequenceVersion="2" change="g.53724_53725del">
            <Expression>NG_008972.2:g.53724_53725del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_030025.1" sequenceAccession="NG_030025" sequenceVersion="1" change="g.119698_119699del">
            <Expression>NG_030025.1:g.119698_119699del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001321978.2" sequenceAccession="NM_001321978" sequenceVersion="2" change="c.*52_*53del">
            <Expression>NM_001321978.2:c.*52_*53del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001321979.2" sequenceAccession="NM_001321979" sequenceVersion="2" change="c.654_655del">
            <Expression>NM_001321979.2:c.654_655del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308908.1" sequenceAccession="NP_001308908" sequenceVersion="1" change="p.Ile218fs">
            <Expression>NP_001308908.1:p.Ile218fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_014317.5" sequenceAccession="NM_014317" sequenceVersion="5" change="c.1164_1165del" MANESelect="true">
            <Expression>NM_014317.5:c.1164_1165del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_055132.2" sequenceAccession="NP_055132" sequenceVersion="2" change="p.Ile388fs">
            <Expression>NP_055132.2:p.Ile388fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1425736863" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00000" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00000" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00001" Source="Trans-Omics for Precision Medicine (TOPMed)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_014317.5(PDSS1):c.1164_1165del (p.Ile388fs) AND Deafness-encephaloneuropathy-obesity-valvulopathy syndrome" Accession="RCV001335650" Version="1">
        <ClassifiedConditionList TraitSetID="8106">
          <ClassifiedCondition DB="MedGen" ID="C3553354">Deafness-encephaloneuropathy-obesity-valvulopathy syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-06-26" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2018-06-26" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-03-22" MostRecentSubmission="2021-03-22">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="8106" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16994" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Coenzyme Q10 deficiency, primary, 2</ElementValue>
                <XRef ID="COENZYME+Q10+DEFICIENCY%2C+PRIMARY%2C+2/7994" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Deafness-encephaloneuropathy-obesity-valvulopathy syndrome</ElementValue>
                <XRef ID="MONDO:0013837" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">COQ10D2</ElementValue>
                <XRef Type="MIM" ID="614651" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Primary coenzyme Q10 (CoQ10) deficiency is usually associated with multisystem involvement, including neurologic manifestations such as fatal neonatal encephalopathy with hypotonia; a late-onset slowly progressive multiple-system atrophy-like phenotype (neurodegeneration with autonomic failure and various combinations of parkinsonism and cerebellar ataxia, and pyramidal dysfunction); and dystonia, spasticity, seizures, and intellectual disability. Steroid-resistant nephrotic syndrome (SRNS), the hallmark renal manifestation, is often the initial manifestation either as isolated renal involvement that progresses to end-stage renal disease (ESRD), or associated with encephalopathy (seizures, stroke-like episodes, severe neurologic impairment) resulting in early death. Hypertrophic cardiomyopathy (HCM), retinopathy or optic atrophy, and sensorineural hearing loss can also be seen.</Attribute>
                <XRef ID="NBK410087" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">28125198</ID>
                <ID Source="BookShelf">NBK410087</ID>
              </Citation>
              <XRef ID="254898" DB="Orphanet" />
              <XRef ID="C3553354" DB="MedGen" />
              <XRef ID="MONDO:0013837" DB="MONDO" />
              <XRef Type="MIM" ID="614651" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3004056" SubmissionDate="2021-03-05" DateLastUpdated="2021-03-22" DateCreated="2021-03-22">
        <ClinVarSubmissionID localKey="NM_014317.3:c.1164_1165delAA|OMIM:614651" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001528841" DateUpdated="2021-03-22" DateCreated="2021-03-22" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-06-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868].</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PDSS1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014317.3:c.1164_1165delAA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614651" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB9201740</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3004056" TraitType="Disease" MappingType="XRef" MappingValue="614651" MappingRef="OMIM">
        <MedGen CUI="C3553354" Name="Deafness-encephaloneuropathy-obesity-valvulopathy syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

